e091 How to Predict Spinopelvic Characteristics Post-Total Hip Arthroplasty: A Prospective Study

e092 Ten-Year Cumulative Incidence and Indications for Revision Total Hip Arthroplasty among Patients with Sickle Cell Disease

e093 Anti-Diabetic Medications' Effect on Outcomes and Glycemic Markers following Total Joint Arthroplasty

e094 Increased Patient Body Mass Index is Associated with Increased Surgeon Physiologic Stress during Total Hip Arthroplasty

e095 Tranexamic Acid is Effective and Safe in High Risk Hip and Knee Arthroplasty Patients